234 related articles for article (PubMed ID: 15035641)
21. Multiple ligand interaction of alpha-synuclein produced various forms of protein aggregates in the presence of Abeta25-35, copper, and eosin.
Kim YS; Lee D; Lee EK; Sung JY; Chung KC; Kim J; Paik SR
Brain Res; 2001 Jul; 908(1):93-8. PubMed ID: 11457435
[TBL] [Abstract][Full Text] [Related]
22. Binding of Abeta to alpha- and beta-synucleins: identification of segments in alpha-synuclein/NAC precursor that bind Abeta and NAC.
Jensen PH; Hojrup P; Hager H; Nielsen MS; Jacobsen L; Olesen OF; Gliemann J; Jakes R
Biochem J; 1997 Apr; 323 ( Pt 2)(Pt 2):539-46. PubMed ID: 9163350
[TBL] [Abstract][Full Text] [Related]
23. Induction of C/EBP beta and GADD153 expression by dopamine in human neuroblastoma cells. Relationship with alpha-synuclein increase and cell damage.
Gómez-Santos C; Barrachina M; Giménez-Xavier P; Dalfó E; Ferrer I; Ambrosio S
Brain Res Bull; 2005 Feb; 65(1):87-95. PubMed ID: 15680548
[TBL] [Abstract][Full Text] [Related]
24. Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.
Takeda A; Hashimoto M; Mallory M; Sundsumo M; Hansen L; Sisk A; Masliah E
Lab Invest; 1998 Sep; 78(9):1169-77. PubMed ID: 9759660
[TBL] [Abstract][Full Text] [Related]
25. Bioinorganic chemistry of Parkinson's disease: structural determinants for the copper-mediated amyloid formation of alpha-synuclein.
Binolfi A; Rodriguez EE; Valensin D; D'Amelio N; Ippoliti E; Obal G; Duran R; Magistrato A; Pritsch O; Zweckstetter M; Valensin G; Carloni P; Quintanar L; Griesinger C; Fernández CO
Inorg Chem; 2010 Nov; 49(22):10668-79. PubMed ID: 20964419
[TBL] [Abstract][Full Text] [Related]
26. beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease.
Masliah E; Rockenstein E; Veinbergs I; Sagara Y; Mallory M; Hashimoto M; Mucke L
Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12245-50. PubMed ID: 11572944
[TBL] [Abstract][Full Text] [Related]
27. Site-specific interactions of Cu(II) with alpha and beta-synuclein: bridging the molecular gap between metal binding and aggregation.
Binolfi A; Lamberto GR; Duran R; Quintanar L; Bertoncini CW; Souza JM; Cerveñansky C; Zweckstetter M; Griesinger C; Fernández CO
J Am Chem Soc; 2008 Sep; 130(35):11801-12. PubMed ID: 18693689
[TBL] [Abstract][Full Text] [Related]
28. Formation of hydrogen peroxide and hydroxyl radicals from A(beta) and alpha-synuclein as a possible mechanism of cell death in Alzheimer's disease and Parkinson's disease.
Tabner BJ; Turnbull S; El-Agnaf OM; Allsop D
Free Radic Biol Med; 2002 Jun; 32(11):1076-83. PubMed ID: 12031892
[TBL] [Abstract][Full Text] [Related]
29. [Alpha-synucleinopathies].
Ferrer I
Neurologia; 2001 Apr; 16(4):163-70. PubMed ID: 11412709
[TBL] [Abstract][Full Text] [Related]
30. Inhibiting aggregation of alpha-synuclein with human single chain antibody fragments.
Emadi S; Liu R; Yuan B; Schulz P; McAllister C; Lyubchenko Y; Messer A; Sierks MR
Biochemistry; 2004 Mar; 43(10):2871-8. PubMed ID: 15005622
[TBL] [Abstract][Full Text] [Related]
31. Toward the discovery of effective polycyclic inhibitors of alpha-synuclein amyloid assembly.
Lamberto GR; Torres-Monserrat V; Bertoncini CW; Salvatella X; Zweckstetter M; Griesinger C; Fernández CO
J Biol Chem; 2011 Sep; 286(37):32036-44. PubMed ID: 21795682
[TBL] [Abstract][Full Text] [Related]
32. Beta-synuclein exhibits chaperone activity more efficiently than alpha-synuclein.
Lee D; Paik SR; Choi KY
FEBS Lett; 2004 Oct; 576(1-2):256-60. PubMed ID: 15474047
[TBL] [Abstract][Full Text] [Related]
33. Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells.
Gómez-Santos C; Ferrer I; Santidrián AF; Barrachina M; Gil J; Ambrosio S
J Neurosci Res; 2003 Aug; 73(3):341-50. PubMed ID: 12868068
[TBL] [Abstract][Full Text] [Related]
34. Self-oligomerization and protein aggregation of alpha-synuclein in the presence of Coomassie Brilliant Blue.
Lee D; Lee EK; Lee JH; Chang CS; Paik SR
Eur J Biochem; 2001 Jan; 268(2):295-301. PubMed ID: 11168363
[TBL] [Abstract][Full Text] [Related]
35. Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments.
El-Agnaf OM; Jakes R; Curran MD; Middleton D; Ingenito R; Bianchi E; Pessi A; Neill D; Wallace A
FEBS Lett; 1998 Nov; 440(1-2):71-5. PubMed ID: 9862428
[TBL] [Abstract][Full Text] [Related]
36. Aggregation of alpha-synuclein induced by the Cu,Zn-superoxide dismutase and hydrogen peroxide system.
Kim KS; Choi SY; Kwon HY; Won MH; Kang TC; Kang JH
Free Radic Biol Med; 2002 Mar; 32(6):544-50. PubMed ID: 11958955
[TBL] [Abstract][Full Text] [Related]
37. NACP/alpha-synuclein, NAC, and beta-amyloid pathology of familial Alzheimer's disease with the E184D presenilin-1 mutation: a clinicopathological study of two autopsy cases.
Yokota O; Terada S; Ishizu H; Ujike H; Ishihara T; Nakashima H; Yasuda M; Kitamura Y; Uéda K; Checler F; Kuroda S
Acta Neuropathol; 2002 Dec; 104(6):637-48. PubMed ID: 12410385
[TBL] [Abstract][Full Text] [Related]
38. Rapid self-assembly of alpha-synuclein observed by in situ atomic force microscopy.
Hoyer W; Cherny D; Subramaniam V; Jovin TM
J Mol Biol; 2004 Jun; 340(1):127-39. PubMed ID: 15184027
[TBL] [Abstract][Full Text] [Related]
39. Neuropathology of synuclein aggregates.
Duda JE; Lee VM; Trojanowski JQ
J Neurosci Res; 2000 Jul; 61(2):121-7. PubMed ID: 10878583
[TBL] [Abstract][Full Text] [Related]
40. Structural transformation and aggregation of human alpha-synuclein in trifluoroethanol: non-amyloid component sequence is essential and beta-sheet formation is prerequisite to aggregation.
Li HT; Du HN; Tang L; Hu J; Hu HY
Biopolymers; 2002 Aug; 64(4):221-6. PubMed ID: 12115139
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
